-+ 0.00%
-+ 0.00%
-+ 0.00%

IBIO INC - PHASE 1 TRIAL OF IBIO-600 TO BEGIN DOSING IN Q2 2026

Reuters·04/08/2026 11:00:01

Please log in to view news